欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Aspirin mixture with Butalbital and Caffeine_51005-25-5_产品详情
51005-25-5
  • Aspirin mixture with Butalbital and Caffeine

  • names:

    2-acetoxybenzoic acid compound with 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione and 5-allyl-5-isobutylpyrimidine-2,4,6(1H,3H,5H)-trione (111)

  • CAS号:

    51005-25-5

    MDL Number:
  • MF(分子式): C28H34N6O9 MW(分子量): 598.61
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Aspirin mixture with Butalbital and Caffeine
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 Aspirin mixture with Butalbital and Caffeine
英文别名 Aspirin mixture with Butalbital and Caffeine; Axotal; Butal Compound; Butalbital aspirin and caffeine
CAS号 51005-25-5
Inchi InChI=1S/C11H16N2O3.C9H8O4.C8H10N4O2/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15;1-6(10)13-8-5-3-2-4-7(8)9(11)12;1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16);2-5H,1H3,(H,11,12);4H,1-3H3
InchiKey YTPUIQCGRWDPTM-UHFFFAOYSA-N
分子式 Formula C28H34N6O9
分子量 Molecular Weight 598.61
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Aspirin mixture with Butalbital and Caffeine(CAS:51005-25-5):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionThis product has been discontinued (DEA controlled substance). Aspirin mixture with Butalbital and Caffeine is combination drug of butalbital, caffeine and aspirin.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501481/ PubMed PMID: 30000541.
[2]Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501467/ PubMed PMID: 30000527.
[3] Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501196/ PubMed PMID: 30000255.
[4] Poyant JO, Albright R, Clain J, Pandompatam G, Barreto EF. Extracorporeal elimination of butalbital in acute aspirin-butalbital-caffeine-codeine (Fiorinal with Codeine) poisoning. Clin Toxicol (Phila). 2018 Jun;56(6):439-441. doi: 10.1080/15563650.2017.1400554. Epub 2017 Nov 10. PubMed PMID: 29124988.
[5] Yeakel JK, Logan BK. Butalbital and driving impairment. J Forensic Sci. 2013 Jul;58(4):941-5. doi: 10.1111/1556-4029.12143. Epub 2013 May 17. PubMed PMID: 23682958.
6: Sohn RS. Comparison of stadol NS and fiorinal with codeine. Headache. 1999 Feb;39(2):137-8. PubMed PMID: 18564449.7: Woodside DB, Colton P, Staab R, Schreiber M, Sutandar-Pinnock K, Poynter B, Sacevich T. Weight restoration in a patient with anorexia nervosa on dialysis. Int J Eat Disord. 2005 Dec;38(4):380-2. PubMed PMID: 16261601.8: Martin VT, Loder E, Taylor K, Almas M, Hilliard B. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study. Cephalalgia. 2005 Sep;25(9):726-34. PubMed PMID: 16109055.9: Goldstein J, Gawel MJ, Winner P, Diamond S, Reich L, Davidson WJ, Sussman NM. Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine. Headache. 1998 Jul-Aug;38(7):516-22. PubMed PMID: 15613167.10: Meatherall R. GC/MS confirmation of barbiturates in blood and urine. J Forensic Sci. 1997 Nov;42(6):1160-70. PubMed PMID: 9397563.1
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents